https://www.biospace.com/axogen-reports-preliminary-unaudited-revenue-for-fourth-quarter-and-full-year-2020
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced...
fourth quarteraxogenreportspreliminaryrevenue
https://www.globenewswire.com/news-release/2017/07/17/1047302/0/en/AxoGen-Inc-Appoints-Jon-Gingrich-Chief-Commercial-Officer.html
ALACHUA, Fla., July 17, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions...
axogenincjongingrichchief